Skip to content

Effect of TNG Perl during pregnancy termination

Investigation of the effect of TNG Perl during pregnancy termination in legal abortion cases.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130914014649N4
Enrollment
140
Registered
2019-01-28
Start date
2018-08-15
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Therapeutic abortion. Complications following (induced) termination of pregnancy

Interventions

Intervention 1: Intervention group: patients will recieve 4 TNG Perl of 0.4 mg made by Zahrawi Pharmacy Company. Patients will be trained to use vaginal capsules at intervals of every 5 hours and are

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnant women with gestational age of 14-19 weeks and gravity of one to four Having a legal abortion license Absence of labor contractions Not having uterine myoma No previous history of uterine surgery Consent to participation in the study

Exclusion criteria

Exclusion criteria: Manifestation of possible complications Cancellation of continuing participation in the study Closeness and clinical examination within the first 24 hours Any problem for the mother which has an indication of immediate termination Prohibition of TNG use (including history of hypotension attacks, palpitations, or severe asthma biases)

Design outcomes

Primary

MeasureTime frame
Rate of abortion. Timepoint: the first 24 hours after admission. Method of measurement: The frequency of abortion after admission.;From the commencement of intervention (reception of Perl) until the end of pregnancy. Timepoint: from the patient's arrival to the hospital until the abortion. Method of measurement: based on number of hours.;Duration of admission. Timepoint: up to 24 hours after medication use. Method of measurement: based on the number of hours recorded in the file.;Need for curettage. Timepoint: After admission in the event of the absence of complete embryo removal after the termination of drug dosage, induction or induction with oxytocin, curettage is carried out. Method of measurement: curettage surgery.;Medicine complications. Timepoint: after drug use commencement. Method of measurement: clinical complications.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomaye Sadat Bagherian

Mashhad University of Medical Sciences

s.bagherian80@gmail.com+98 51 3802

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026